See how AI can improve programmatic media planning, monitoring and investment decisions while keeping human expertise and oversight at the center.

Learn how adaptive deployment models help pharma customer-facing teams use AI, flex capacity, and respond faster as market conditions change.

Our oncology expert breaks down how AI in oncology analyzes target expression and the tumor microenvironment to improve solid tumor indication selection and clinical development.

Explore the ART framework for Japanese pharmaceutical companies to align asset strategy, market entry routes and timing for global commercialization.

For cell and gene therapy developers, reaching first-in-human studies is only the beginning. Decisions made at this stage can shape clinical execution, manufacturing scalability...

Explore how pharmaceutical companies can prepare for Korea's evolving reimbursement and post-listing performance assessment environment.